Terazosin Hydrochloride
- Product NDC
- 24689-855
- 11-digit product format
- 246890855
- Labeler code
- 24689
- Product ID
- 24689-855_2d125642-5083-4147-e063-6394a90a329c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Apnar Pharma LP
- Application
- ANDA074823
- Marketing category
- ANDA
- Marketing start
- 2020-06-30
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 24689-855-01 | Terazosin Hydrochloride | 100 in 1 BOTTLE | CAPSULE | 100 | | 12 |
| 24689-855-03 | Terazosin Hydrochloride | 90 in 1 BOTTLE | CAPSULE | 90 | | 12 |
| 24689-855-10 | Terazosin Hydrochloride | 1000 in 1 BOTTLE | CAPSULE | 1000 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 24689-855 | TERAZOSIN HYDROCHLORIDE CAPSULE [APNAR PHARMA LP] | 12 | Current NDC, Legacy NDC, 3 package rows | 20250210_a9176551-3da9-34c1-e053-2995a90a3aee.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 24689-855-01 | 24689085501 | 100 CAPSULE in 1 BOTTLE (24689-855-01) | 100 capsule | 2020-06-30 | 0000-00-00 | No | No | Current |
| 24689-855-03 | 24689085503 | 90 CAPSULE in 1 BOTTLE (24689-855-03) | 90 capsule | 2025-02-15 | | No | No | Historical |
| 24689-855-10 | 24689085510 | 1000 CAPSULE in 1 BOTTLE (24689-855-10) | 1000 capsule | 2020-06-30 | 0000-00-00 | No | No | Current |